Evaluation of (64)Cu-Based Radiopharmaceuticals that Target Aβ Peptide Aggregates as Diagnostic Tools for Alzheimer’s Disease

[Image: see text] Positron emission tomography (PET) imaging agents that detect amyloid plaques containing amyloid beta (Aβ) peptide aggregates in the brain of Alzheimer’s disease (AD) patients have been successfully developed and recently approved by the FDA for clinical use. However, the short hal...

Descripción completa

Detalles Bibliográficos
Autores principales: Bandara, Nilantha, Sharma, Anuj K., Krieger, Stephanie, Schultz, Jason W., Han, Byung Hee, Rogers, Buck E., Mirica, Liviu M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2017
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5677763/
https://www.ncbi.nlm.nih.gov/pubmed/28823165
http://dx.doi.org/10.1021/jacs.7b05937

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5677763/
https://www.ncbi.nlm.nih.gov/pubmed/28823165
http://dx.doi.org/10.1021/jacs.7b05937

Ejemplares similares